Eqis Capital Management, Inc. Viatris Inc Transaction History

Eqis Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $100,519 - $133,952	10,926 Added 45.32%	35,035 $337,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $210,230 - $278,700	24,109 New	24,109 $268,000
Q2 2022 Aug 08, 2022	BUY	$9.95 - $12.27 $28,347 - $34,957	2,849 Added 18.38%	18,350 $192,000
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $13,684 - $21,483	-1,395 Reduced 8.26%	15,501 $169,000
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $9,913 - $12,037	-820 Reduced 4.63%	16,896 $229,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $728 - $832	-55 Reduced 0.31%	17,716 $240,000
Q2 2021 Aug 12, 2021	SELL	$12.97 - $16.15 $3,281 - $4,085	-253 Reduced 1.4%	17,771 $254,000
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $244,946 - $334,164	18,024 New	18,024 $252,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.